Nanoviricides NNVC
NYSE NNVC
$1.43 -0.08 (-5.25%)
As of: Oct 22, 2026 · 2:31 PM EDT

Nanoviricides (NNVC) Share-based Compensation (2014 - 2026)

Updated

Nanoviricides' Share-based Compensation came in at $38,252 for fiscal Q4 2026 (quarter ended Jun 30, 2026), unchanged from $38,250 a year earlier and down 32.0% from the prior quarter.

Analysis

Nanoviricides (NNVC) Share-based Compensation (2014 - 2026) Analysis & Trends

For FY2026 (ended Jun 30, 2026), Nanoviricides' Share-based Compensation was $317,833, up 95.4% from FY2025.

  • Share-based Compensation carries a five-year compound annual growth rate of 12.1% (FY2021 to FY2026).
  • Going back by fiscal year, Share-based Compensation was $162,625 in FY2025 (-9.1%), $178,940 in FY2024 (+13.4%), $157,822 in FY2023 (-22.3%) and $203,018 in FY2022 (+13.2%).
  • The five-year range for quarterly Share-based Compensation is $38,250 (fiscal Q1 2023) to $185,100 (fiscal Q2 2026).
  • Year-over-year, Share-based Compensation increased in two of the last eight quarters, with growth averaging 47.5%.
  • The fastest year-over-year change in Share-based Compensation over five years came in fiscal Q2 2026 (growth of 383.9%), and the weakest in fiscal Q4 2023 (a decline of 48.3%).
  • Business Quant data shows NNVC's Share-based Compensation at $56,231 (Q3 2026), $185,100 (Q2 2026) and $38,250 (Q1 2026) in the three fiscal quarters before Q4 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Stock Comp. (Qtr)
1 Eli Lilly 1,167.12 Bn 1,135.70 Bn 19.71 Bn 201.00 Mn
2 Johnson & Johnson 647.48 Bn 567.35 Bn 17.30 Bn 357.00 Mn
3 AbbVie 502.73 Bn 475.84 Bn 12.70 Bn 166.00 Mn
4 Merck 363.86 Bn 318.23 Bn 12.21 Bn 298.00 Mn
5 Novartis Ag 303.31 Bn 267.30 Bn 11.24 Bn -
6 Astrazeneca 269.08 Bn 242.77 Bn 12.86 Bn -
7 Amgen 242.07 Bn 197.46 Bn 7.24 Bn 165.00 Mn
8 Gilead Sciences 194.93 Bn 169.12 Bn 6.22 Bn 231.00 Mn
9 Pfizer 172.42 Bn 119.07 Bn 10.94 Bn 249.00 Mn
10 Nanoviricides 29.07 Mn 16.73 Mn - 38,252.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 38,252.00
Mar 31, 2026 56,231.00
Dec 31, 2025 185,100.00
Sep 30, 2025 38,250.00
Jun 30, 2025 38,250.00
Mar 31, 2025 40,375.00
Dec 31, 2024 38,250.00
Sep 30, 2024 45,750.00
Jun 30, 2024 38,250.00
Mar 31, 2024 40,590.00
Dec 31, 2023 38,250.00
Sep 30, 2023 61,850.00
Jun 30, 2023 38,250.00
Mar 31, 2023 43,072.00
Dec 31, 2022 38,250.00
Sep 30, 2022 38,250.00
Jun 30, 2022 74,000.00
Mar 31, 2022 45,018.00
Dec 31, 2021 42,000.00
Sep 30, 2021 42,000.00
API Access

Nanoviricides Share-based Compensation API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=share-based-compensation&ticker=NNVC&period=max&api_key=YOUR_API_KEY